Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
CYNOSURE INC (0000885306)
Standardized SEC financial data for CYNOSURE INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000885306 · Electromedical & Electrotherapeutic Apparatus.
Gross margin
87.3%
Operating margin
9.0%
Net margin
10.7%
Revenue growth (YoY)
29.4%
Return on equity
6.9%
Free cash flow
$31.6M
Current ratio
3.21×
EPS (diluted)
$1.41
Ratios for fiscal year 2014, standardized from SEC filings.
Income statement
USD
FY2016
Cost of revenue
$178.2M
Gross profit
$255.3M
R&D expense
$29.0M
SG&A expense
$153.9M
Interest expense
$18K
Pretax income
$24.9M
Income tax
$10.7M
Standardized from CYNOSURE INC's SEC filings — per-share figures split-adjusted. Full history via the API.